Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects

Journal of Psychiatric Research

Volumn 56, Issue 1, 2014, Pages 28-35

  Carmel, Miri ^a   Zarchi, Omer ^a,b,e   Michaelovsky, Elena ^a   Frisch, Amos ^a   Patya, Miriam ^a   Green, Tamar ^a,b,c   Gothelf, Doron ^a,b   Weizman, Abraham ^a,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c BEER YAAKOV MENTAL HEALTH CENTER   (Israel)

^d GEHA MENTAL HEALTH CENTER   (Israel)

^e RABIN MEDICAL CENTER   (Israel)

Author keywords

22q11.2DS; COMT; Executive function (EF); Intelligence quotient (IQ)

Indexed keywords

CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN; PRODH PROTEIN, HUMAN; PROLINE DEHYDROGENASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME DELETION 22Q11; EXECUTIVE FUNCTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; YOUNG ADULT; ATTENTION DEFICIT DISORDER; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIGEORGE SYNDROME; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN DEVELOPMENT; INTELLIGENCE; INTELLIGENCE TEST; MAJOR DEPRESSION; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOSIS;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DIGEORGE SYNDROME; EXECUTIVE FUNCTION; GENETIC PREDISPOSITION TO DISEASE; HUMAN DEVELOPMENT; HUMANS; INTELLIGENCE; INTELLIGENCE TESTS; MALE; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, GENETIC; PROLINE OXIDASE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84903787349     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.04.019     Document Type: Article

References (56)

1. Abou Jamra R., Schumacher J., Becker T., Dahdouh F., Ohlraun S., Suliman H., et al. No evidence for an association between variants at the proline dehydrogenase locus and schizophrenia or bipolar affective disorder. Psychiatr Genet 2005, 15(3):195-198.
2. Antshel K.M., Shprintzen R., Fremont W., Higgins A.M., Faraone S.V., Kates W.R. Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome: a 3-year follow-up study. JAm Acad Child Adolesc Psychiatry 2010, 49(4):333-344.
3. Baker K., Baldeweg T., Sivagnanasundaram S., Scambler P., Skuse D. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome. Biol Psychiatry 2005, 58(1):23-31.
4. Barnett J.H., Heron J., Goldman D., Jones P.B., Xu K. Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children. Am J Psychiatry 2009, 166(8):909-916.
5. Barnett J.H., Heron J., Ring S.M., Golding J., Goldman D., Xu K., et al. Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children. Am J Psychiatry 2007, 164(1):142-149.
6. Barnett J.H., Jones P.B., Robbins T.W., Müller U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry 2007, 12(5):502-509.
7. Barnett J.H., Scoriels L., Munafò M.R. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry 2008, 64(2):137-144.
8. Bearden C.E., Jawad A.F., Lynch D.R., Sokol S., Kanes S.J., McDonald-McGinn D.M., et al. Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am J Psychiatry 2004, 161(9):1700-1702.
9. Bender H.U., Almashanu S., Steel G., Hu C.A., Lin W.W., Willis A., et al. Functional consequences of PRODH missense mutations. Am J Hum Genet 2005, 76(3):409-420.
10. Bender S., Rellum T., Freitag C., Resch F., Rietschel M., Treutlein J., et al. Dopamine inactivation efficacy related to functional DAT1 and COMT variants influences motor response evaluation. PLoS One 2012, 7(5):e37814.
11. Bish J.P., Ferrante S.M., McDonald-McGinn D., Zackai E., Simon T.J. Maladaptive conflict monitoring as evidence for executive dysfunction in children with chromosome 22q11.2 deletion syndrome. Dev Sci 2005, 8(1):36-43.
12. Blanchard M.M., Chamberlain S.R., Roiser J., Robbins T.W., Müller U. Effects of two dopamine-modulating genes (DAT1 9/10 and COMT Val/Met) on n-back working memory performance in healthy volunteers. Psychol Med 2011, 41(3):611-618.
13. Caplan R., Arbelle S., Guthrie D., Komo S., Shields W.D., Hansen R., et al. Formal thought disorder and psychopathology in pediatric primary generalized and complex partial epilepsy. JAm Acad Child Adolesc Psychiatry 1997, 36(9):1286-1294.
14. Daniels J.K., Williams N.M., Williams J., Jones L.A., Cardno A.G., Murphy K.C., et al. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry 1996, 153(2):268-270.
15. Diamond A., Barnett W.S., Thomas J., Munro S. Preschool program improves cognitive control. Science 2007, 318(5855):1387-1388.
16. Diaz-Asper C.M., Goldberg T.E., Kolachana B.S., Straub R.E., Egan M.F., Weinberger D.R. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Biol Psychiatry 2008, 63(1):72-79.
17. Drew L.J., Crabtree G.W., Markx S., Stark K.L., Chaverneff F., Xu B., et al. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int J Dev Neurosci 2011, 29(3):259-281.
18. Duijff S.N., Klaassen P.W., de Veye H.F., Beemer F.A., Sinnema G., Vorstman J.A. Cognitive development in children with 22q11.2 deletion syndrome. Br J Psychiatry 2012, 200(6):462-468.
19. Dumontheil I., Roggeman C., Ziermans T., Peyrard-Janvid M., Matsson H., Kere J., et al. Influence of the COMT genotype on working memory and brain activity changes during development. Biol Psychiatry 2011, 70(3):222-229.
20. Fan J.B., Ma J., Zhang C.S., Tang J.X., Gu N.F., Feng G.Y., et al. Afamily-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population. Neurosci Lett 2003, 338(3):252-254.
21. Farrell S.M., Tunbridge E.M., Braeutigam S., Harrison P.J. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition. Biol Psychiatry 2012, 71(6):538-544.
22. Gaysina D., Xu M.K., Barnett J.H., Croudace T.J., Wong A., Richards M., et al. LHA genetics group. The catechol-O-methyltransferase gene (COMT) and cognitive function from childhood through adolescence. Biol Psychol 2013, 92(2):359-364.
23. Glaser B., Debbane M., Hinard C., Morris M.A., Dahoun S.P., Antonarakis S.E., et al. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome. Am J Psychiatry 2006, 163(3):537-539.
24. Glaser B., Moskvina V., Kirov G., Murphy K.C., Williams H., Williams N., et al. Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility. Schizophrenia Res 2006, 87(1-3):21-27.
25. Gothelf D., Eliez S., Thompson T., Hinard C., Penniman L., Feinstein C., et al. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 2005, 8(11):1500-1502.
26. Gothelf D., Schneider M., Green T., Debban M., Frisch A., Glaser B., et al. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. JAm Acad Child Adolesc Psychiatry 2013, 52(11):1192-1203.
27. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 2010, 11(6):402-416. PMID: 20485365.
28. Kempf L., Nicodemus K.K., Kolachana B., Vakkalanka R., Verchinski B.A., Egan M.F., et al. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet 2008, 4(11):e1000252. 1-9.
29. Kimoto S., Muraki K., Toritsuka M., Mugikura S., Kajiwara K., Kishimoto T., et al. Selective overexpression of Comt in prefrontal cortex rescues schizophrenia-like phenotypes in a mouse model of 22q11 deletion syndrome. Transl Psychiatry 2012, 2(8):e146. 1-16.
30. Knickmeyer R.C., Wang J., Zhu H., Geng X., Woolson S., Hamer R.M., et al. Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex 2014, 24(5):1230-1246.
31. Li T., Ma X., Hu X., Wang Y., Yan C., Meng H., et al. PRODH gene is associated with executive function in schizophrenic families. Am J Med Genet Part B (Neuropsychiatr Genet) 2008, 147B(5):654-657.
32. Niarchou M., Zammit S., van Goozen S.H., Thapar A., Tierling H.M., Owen M.J., et al. Psychopathology and cognition in children with 22q11.2 deletion syndrome. Br J Psychiatry 2014, 204(1):46-54.
33. Ohtsuki T., Tanaka S., Ishiguro H., Noguchi E., Arinami T., Tanabe E., et al. Failure to find association between PRODH deletion and schizophrenia. Schizophrenia Res 2004, 67(1):111-113.
34. Parasuraman R., Jiang Y. Individual differences in cognition, affect, and performance: behavioral, neuroimaging, and molecular genetic approaches. NeuroImage 2012, 59(1):70-82.
35. Paterlini M., Zakharenko S.S., Lai W.S., Qin J., Zhang H., Mukai J., et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 2005, 8(11):1586-1594.
36. Philip N., Bassett A. Cognitive, behavioural and psychiatric phenotype in 22q11.2 deletion syndrome. Behav Genet 2011, 41(3):403-412.
37. Rasetti R., Weinberger D.R. Intermediate phenotypes in psychiatric disorders. Curr Opin Genet Dev 2011, 21(3):340-348.
38. Raux G., Bumsel E., Hecketsweiler B., van Amelsvoort T., Zinkstok J., Manouvrier-Hanu S., et al. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum Mol Genet 2007, 16(1):83-91.
39. Roussos P., Giakoumaki S.G., Bitsios P. Arisk PRODH haplotype affects sensorimotor gating, memory, schizotypy, and anxiety in healthy male subjects. Biol Psychiatry 2009, 65(12):1063-1070.
40. Shapiro H.M., Takarae Y., Harvey D.J., Cabaral M.H., Simon T.J. Across-sectional study of the development of volitional control of spatial attention in children with chromosome 22q11.2 deletion syndrome. JNeurodev Disord 2012, 4(1):5. 1-12.
41. Shapiro H.M., Wong L.M., Simon T.J. Across-sectional analysis of the development of response inhibition in children with chromosome 22q11.2 deletion syndrome. Front Psychiatry 2013, 4(81):1-10.
42. Shashi V., Francis A., Hooper S.R., Kranz P.G., Zapadka M., Schoch K., et al. Increased corpus callosum volume in children with chromosome 22q11.2 deletion syndrome is associated with neurocognitive deficits and genetic polymorphisms. Eur J Hum Genet 2012, 20(10):1051-1057.
43. Shashi V., Keshavan M.S., Howard T.D., Berry M.N., Basehore M.J., Lewandowski E., et al. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome. Clin Genet 2006, 69(3):234-238.
44. Simon T.J., Bish J.P., Bearden C.E., Ding L., Ferrante S., Nguyen V., et al. Amultilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children. Dev Psychopathol 2005, 17(3):753-784.
45. Sobin C., Kiley-Brabeck K., Daniels S., Blundell M., Anyane-Yeboa K., Karayiorgou M. Networks of attention in children with the 22q11 deletion syndrome. Dev Neuropsychol 2004, 26(2):611-626.
46. Squarcione C., Torti M.C., Di Fabio F., iondi M. 22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis. Neuropsychiatr Dis Treat 2013, 9:1873-1884.
47. Stoddard J., Beckett L., Simon T.J. Atypical development of the executive attention network in children with chromosome 22q11.2 deletion syndrome. JNeurodev Disord 2011, 3(1):76-85.
48. Takarae Y., Schmidt L., Tassone F., Simon T.J. Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome. Cognitive, Affect Behav Neurosci 2009, 9(1):83-90.
49. Vorstman J.A., Turetsky B.I., Sijmens-Morcus M.E., de Sain M.G., Dorland B., Sprong M., et al. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology 2009, 34(3):739-746.
50. Wechsler D. Wechsler Intelligence Scale for children 1991, Psychological Corporation, San Antonio, TX. 3rd ed.
51. Williams H.J., Williams N., Spurlock G., Norton N., Ivanov D., McCreadie R.G., et al. Association between PRODH and schizophrenia is not confirmed. Mol Psychiatry 2003, 8(7):644-645.
52. Williams H.J., Williams N., Spurlock G., Norton N., Zammit S., Kirov G., et al. Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia. Am J Med Genet Part B, Neuropsychiatric Genet 2003, 120B(1):42-46.
53. Witte A.V., Flöel A. Effects of COMT polymorphisms on brain function and behavior in health and disease. Brain Res Bull 2012, 88(5):418-428.
54. Zarchi O., Carmel M., Avni C., Attias J., Frisch A., Michaelovsky E., et al. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes. JPsychiatric Res 2013, 47(11):1623-1629.
55. Zarchi O., Diamond A., Weinberger R., Abbott D., Carmel M., Frisch A., et al. Acomparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: Velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes. Eur Psychiatry 2013, pii: S0924-9338(13)00097-7. 10.1016/j.eurpsy.2013.07.001.
56. Zinkstok J., Schmitz N., van Amelsvoort T., Moeton M., Baas F., Linszen D. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes Brain, Behav 2008, 7(1):61-69.